Parametric Portfolio Associates’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.89M	Sell	17,086 -1,415	-8%	-$176K	﹤0.01%	2447
2021 Q4	$1.78M	Sell	18,501 -1,041	-5%	-$104K	﹤0.01%	2501
2021 Q3	$1.71M	Buy	19,542 +8,044	+70%	+$835K	﹤0.01%	2525
2021 Q2	$1.78M	Buy	11,498 +5,624	+96%	+$816K	﹤0.01%	2501
2021 Q1	$927K	Buy	5,874 +609	+12%	+$128K	﹤0.01%	3201
2020 Q4	$1.22M	Buy	5,265 +2,229	+73%	+$517K	﹤0.01%	2943
2020 Q3	$665K	Sell	3,036 -6,604	-69%	-$1.62M	﹤0.01%	3125
2020 Q2	$2.74M	Sell	9,640 -914	-9%	-$270K	﹤0.01%	2299
2020 Q1	$3.04M	Buy	10,554 +3,794	+56%	+$1.05M	﹤0.01%	2108
2019 Q4	$1.94M	Buy	6,760 +5,076	+301%	+$1.1M	﹤0.01%	2706
2019 Q3	$243K	Buy	1,684 +257	+18%	+$34.8K	﹤0.01%	3632
2019 Q2	$128K	Buy	+1,427	New	+$115K	﹤0.01%	3809
2017 Q3	–	Sell	-1,306	Closed	-$177K	–	4040
2017 Q2	$177K	Sell	1,306 -560	-30%	-$82.9K	﹤0.01%	3847
2017 Q1	$359K	Buy	1,866 +519	+39%	+$83.3K	﹤0.01%	3364
2016 Q4	$190K	Buy	1,347 +19	+1%	+$2.57K	﹤0.01%	3605
2016 Q3	$194K	Buy	+1,328	New	+$160K	﹤0.01%	3579
2015 Q3	–	Sell	-753	Closed	-$307K	–	3305
2015 Q2	$307K	Buy	+753	New	+$325K	﹤0.01%	3558
2015 Q1	–	Sell	-747	Closed	-$419K	–	3973
2014 Q4	$419K	Buy	+747	New	+$424K	﹤0.01%	3363